Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
With regard to their figures for mortality, it is also important to look at other causes of death, such as bleeding and complications arising from wound sepsis.2 How many deaths were due to these problems? In figure 1 they indicate that hospitals 3, 5, 7, and 8 were low users of antithrombotic prophylaxis. The 90 day survival curves indicate, however, that there was little difference in overall mortality between the hospitals other than hospital 6 (if there was any, hospitals 3, 5, 7, and 8 seem to have had slightly better survival than hospitals 1, 2, and 4). The authors' data show that the overall mortality in hospitals 1, 2, 4, and 6 (which used antithrombotic prophylaxis more frequently) was 20% at 90 days while that in hospitals 3, 5, 7, and 8 was 18%. Thus while fatal pulmonary embolism may be more common when antithrombotic prophylaxis is not used, overall mortality may not be very different between patients in whom it is used and those in whom it is not. It would thus be interesting to know what the overall mortality was in each group of patients.
An important concern regarding routine use of antithrombotic prophylaxis is an increase in the incidence of complications related to the wound. Was there any difference in the overall infection rate between the patients who had antithrombotic prophylaxis and those who did not?
Consultant orthopaedic surgeon Homerton Hospital NHS Trust, London E9 6SR
K C Kong
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.